AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimwik M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Biocube Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimwik M 2mg/500mg Tablet

Diabetic patients using Glucomax-M 2mg/500mg tablets, classified as antidiabetic agents, receive a dual-action medication for managing type 2 diabetes. This combination therapy effectively regulates blood glucose in adult patients. Glucomax-M 2mg/500mg tablets are administered with food, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician based on blood glucose monitoring and response. Continuous use is crucial; discontinuation without medical consultation may lead to elevated blood sugar, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan, encompassing a healthy diet, regular exercise, and weight management as advised by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headaches, and tremors. Learn to recognize and treat hypoglycemia promptly. Maintaining regular mealtimes and carrying a fast-acting glucose source, like sugary snacks or juice, is essential. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headaches, and upper respiratory infections. Weight gain is also possible. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or breastfeeding individuals should seek medical advice. Regular blood glucose monitoring is necessary, along with periodic blood tests to assess blood cell counts and liver function as directed by your healthcare provider.

Primary Ingredients of Glimwik M 2mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glimwik M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimwik M 2mg/500mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimwik M 2mg/500mg tablets with food.

Common Side effects of Glimwik M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimwik M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimwik M 2mg/500mg Tablet whole; do not crush, chew, or divide it. Administer this medicine with a meal.

How Glimwik M 2mg/500mg Tablet works:

Glimwik M, a 2mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimwik M 2mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimwik M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimwik M 2mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimwik M 2mg/500mg tablets to individuals with kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Glimwik M 2mg/500mg tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimwik M 2mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiating treatment with a low dose of Glimwik M 2mg/500mg tablets is typical; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimwik M 2mg/500mg Tablet :

Should you forget to take your Glimwik M 2mg/500mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Glimwik M 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Category Medication for diabetes

FAQs on Glimwik M 2mg/500mg Tablet

Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of taking Glimwik M 2mg/500mg Tablet. This adverse reaction, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with impaired kidney function, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should any of these symptoms appear, discontinue Glimwik M 2mg/500mg Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimwik M 2mg/500mg tablets, manage type 2 diabetes mellitus (DM) in adults. This dual therapy enhances blood sugar control when coupled with a healthy diet and exercise regimen. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin's action involves decreasing hepatic glucose production and increasing insulin responsiveness. This medication is unsuitable for type 1 DM.
Taking Glimwik M 2mg/500mg tablets may cause common side effects such as low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headaches. Rare but serious adverse reactions, including lactic acidosis, are also possible. Prolonged use might result in vitamin B12 deficiency.
Indeed, prolonged Glimwik M 2mg/500mg Tablet use can lead to Vitamin B12 deficiency. This medication hinders Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications, including paresthesia in the extremities, general weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum annually, has been proposed by some investigators.
Glimwik M 2mg/500mg Tablets can induce hypoglycemia (low blood sugar). This can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available fast-acting sugar source such as glucose tablets, honey, or fruit juice.
Combining Glimwik M 2mg/500mg tablets and alcohol is unsafe. This combination can reduce blood sugar, potentially causing hypoglycemia, and raises the risk of lactic acidosis.
Glimwik M 2mg/500mg Table...
74
MRP 90
17% off